Endo, Inc. Adjusts Financial Results and Conference Call Date

Endo, Inc. Adjusts Financial Results Release Date
Endo, Inc. (OTCQX: NDOI), a leading pharmaceutical company, has announced a change in the schedule for releasing its financial results for the fourth quarter and full year 2024. Instead of the previously planned date, the company will now unveil its financial results on March 13, 2025, before the market opens, allowing investors and stakeholders to analyze the data in a timely manner.
Conference Call Scheduled for Investors
Alongside the release of its financial results, Endo will hold a conference call on the same day—March 13, 2025—at 8:00 a.m. ET. This call will provide investors and interested parties an opportunity to hear directly from the company’s management about the financial performance and outlook for the business.
How to Access the Conference Call
To participate in the conference call, investors can dial into the provided numbers: 800-836-8184 for U.S. and Canada residents, or 646-357-8785 for international callers. It is advisable for participants to join the call at least 10 minutes before it begins to ensure a smooth experience. Additionally, an audio webcast of the call will be accessible through the Investor Relations section of the Endo website, where participants can listen to the discussion live or view a replay afterward.
About Endo, Inc.
Endo, Inc. specializes in developing transformational pharmaceuticals that aim to improve patients' lives. The company’s dedicated team is committed to turning innovative insights into tangible therapies that address various medical needs. This commitment drives them to help every individual live the healthiest and fullest life possible, ensuring that their products contribute positively to the well-being of countless people.
Staying Connected
For those interested in learning more about Endo's ongoing projects and updates, the company encourages visitors to explore their official website. Additionally, engaging with Endo through their social media platforms, including LinkedIn, offers further insights into the company culture and its array of healthcare solutions.
Conclusion
As Endo, Inc. prepares for this upcoming financial reporting and conference call, stakeholders can look forward to receiving crucial information that will inform their understanding of the company’s direction and market position. With a focus on transparency and engagement, Endo continues to uphold its commitment to its investors and the broader healthcare community.
Frequently Asked Questions
What is the new date for Endo's earnings release?
The earnings release is now scheduled for March 13, 2025.
What time is the conference call for investors?
The conference call will occur at 8:00 a.m. ET on the same day as the earnings release.
How can investors join the conference call?
Investors can dial 800-836-8184 for U.S. callers or 646-357-8785 for international participation.
Where can I access more information about Endo, Inc.?
More information can be found by visiting Endo’s official website and its Investor Relations section.
What does Endo, Inc. focus on?
Endo focuses on developing pharmaceuticals that enhance the quality of life for patients.
About The Author
Contact Olivia Taylor privately here. Or send an email with ATTN: Olivia Taylor as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.